← Back to Search

Behavioral Intervention

Amygdala Insula Retraining for Post-COVID Syndrome

N/A
Waitlist Available
Research Sponsored by Miami VA Healthcare System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have no evidence of cardiac or pulmonary end organ damage, as per WHO definition. We will define not having end organ damage as a normal ejection fraction on echocardiogram and no pulmonary infiltrates on a non-contrast computed tomography (CT) of the chest during the work-up of the long COVID clinic.
A probable or confirmed diagnosis of acute COVID-19 infection as per WHO guidelines.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial will compare a mind-body intervention to usual care in people with long COVID to see if it helps reduce fatigue & improve lab markers.

Who is the study for?
This trial is for individuals who have had COVID-19 and are now experiencing long-term fatigue, without any heart or lung damage. Participants must have been diagnosed with post-COVID syndrome, be patients at the Miami VA post-COVID clinic, and have access to a computer or phone.Check my eligibility
What is being tested?
The study tests amygdala insula retraining as an additional treatment to usual care for managing fatigue in long COVID patients. It will also explore if this mind-body intervention can affect lab markers, heart rate variability, and dysautonomia.See study design
What are the potential side effects?
Since amygdala insula retraining is a non-invasive mind-body technique focusing on mental exercises and relaxation strategies, it typically does not cause physical side effects. However, individual experiences may vary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My heart and lungs are functioning normally according to tests.
Select...
I have been diagnosed with COVID-19 following WHO guidelines.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Modified Yorkshire COVID-19 scale
Secondary outcome measures
COMPASS-31
Heart rate variability

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Mind body intervention + Usual care: The intervention will be delivered virtually
Group II: Control armActive Control1 Intervention
The participants in the comparator group will be wait listed for the intervention

Find a Location

Who is running the clinical trial?

Miami VA Healthcare SystemLead Sponsor
17 Previous Clinical Trials
2,271 Total Patients Enrolled

Media Library

Amygdala Insula Retraining (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05851846 — N/A
COVID-19 Research Study Groups: Intervention, Control arm
COVID-19 Clinical Trial 2023: Amygdala Insula Retraining Highlights & Side Effects. Trial Name: NCT05851846 — N/A
Amygdala Insula Retraining (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05851846 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this investigation currently enrolling participants?

"According to clinicialtrials.gov, this medical trial is not recruiting at this time; the first posting was on May 15th 2023 and the most recent update occurred eight days ago. Despite its lack of recruitment, there are still 47 other trials actively seeking patients right now."

Answered by AI

Who else is applying?

What site did they apply to?
Miami VAHS
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

I still feel fatigue, headaches, loss of smell and taste.
PatientReceived 1 prior treatment
Recent research and studies
clinicaltrials.govStudy
Amygdala Insula Retraining in the Management of Long COVID Symptoms
Leonardo Tamariz 2023. "Amygdala Insula Retraining in the Management of Long COVID Symptoms". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05851846.
All > Survivor Corps
~0 spots leftby May 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top